Specifically, ADMA levels were progressively higher in patients with stable COPD and reached their peak during acute exacerbations, whereas NO and eNOS levels were highest in healthy controls and gradually decreased in patients with stable and exacerbated COPD. Here, NOS3 is linked to chronic obstructive pulmonary disease.